Financing channel feed – Endpoints News

Financing channel feed

Relay and iTeos join IPO deluge while Akouos and Fusion decide they can earn more

5 years ago

Takeda joins microbiome-focused biotech partner's $52.6M raise as it pursues more in-house cancer work

5 years ago

Yale spinout re-engineers an immunotherapy GSK, others once abandoned

5 years ago

Biogeneration Ventures raises $119M for new fund, adding a personal record to series of VC raises

5 years ago

A virtual biotech incubator is launching with the help of Evotec and Samsara, looking for a few good scientists in need of seed cash for spinouts

5 years ago

Better than Eylea, as durable as gene therapy? Perceptive, Xontogeny boost ophthalmic startup's shot for best of all worlds

5 years ago

What’s it take to raise $700M-plus for a biotech startup? Steve Harr has some thoughts on that

5 years ago

Trans-Atlantic VC banks $126M to scout startup ideas out of 'underventured' areas in the UK

5 years ago

Cell and gene therapy 2.0 dominates latest round of biotech IPOs in scramble for a $300M-plus Nasdaq windfall

5 years ago

Surrozen reloads with $50M for final dash to the clinic, shines some light on lead Wnt-modulating candidates

5 years ago

Prominent Harvard professor in the hunt for $100M to back his anti-aging play

5 years ago

The biotech IPOs keep coming at chart-topping levels — with no slowdown in sight

5 years ago

Nan Fung Life Sciences antes up $32M to fuel a neuro play as the Hong Kong conglomerate burns through $1.5B mandate

5 years ago

All in on IL-11, Frazier unveils latest startup with dual focus on fibrosis and cancer

5 years ago

A Bay Area upstart with legendary godfathers breaks cover, touting claims of a curative tech, unicorn status and a $300M plan to shoot for an approval

5 years ago

Pablo capitalized: Royalty Pharma scores $2.2B IPO — the biggest of the year

5 years ago

Eyeing a hot IPO market, 4DMT tops up its cash reserves and preps a leap into the clinic with bespoke gene therapy vectors

5 years ago

Shattuck Labs ends silence with a shout-out on $118M raise for fusion protein work

5 years ago

SK Biopharmaceuticals emerges from pandemic with pitch for $822M IPO

5 years ago

Covid-19 roundup: Catalent lends vaccine production capacity to AstraZeneca/Oxford for hundreds of millions doses

5 years ago

Sure, Bit Bio got some significant cash for its cell coding work. But it’s the insiders who are backing them that will garner the attention

5 years ago

The pandemic IPOs keep rolling, as Generation, Avidity, Vaxcyte each claim 200M+

5 years ago

A storied Chinese pharma partner of Bristol Myers, Amgen — and avid biotech supporter — plots HK IPO

5 years ago

Juno, WuXi JV in China score $100M in fresh funding as it sets stage for first CAR-T approval

5 years ago

First page Previous page 96 97 9899100 101 102 Next page Last page